Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Uterine Neoplasms 1Urinary Bladder Neoplasms 1Skin Neoplasms 1Kidney Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

pembrolizumab 3Nivolumab 3Ipilimumab 2Interleukin-2 2Drug Therapy 2Biopsy 2pertuzumab 1osimertinib 1montanide ISA 51 1liposomal doxorubicin 1cobimetinib 1brodalumab 1atezolizumab 1Trastuzumab 1Tissue Banks 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Quality of Life 1Psychiatric Rehabilitation 1Poly I-C 1Photochemotherapy 1Patient Reported Outcome Measures 1Paclitaxel 1Oxaliplatin 1Observation 1Molecular Diagnostic Techniques 1Mass Screening 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Neoplasms × Health × Gastrointestinal × Clear all
NCT01447199 2020-01-07

The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)

M.D. Anderson Cancer Center

Unknown
2,000 enrolled
DermatologicGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Kidney Neoplasms, Skin Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡